Microbiome hypothesis: Difference between revisions
From MEpedia, a crowd-sourced encyclopedia of ME and CFS science and history
Notjusttired (talk | contribs) m (fix ref) |
Notjusttired (talk | contribs) m (Text replacement - " | doi" to " | doi") |
||
| (53 intermediate revisions by the same user not shown) | |||
| Line 9: | Line 9: | ||
*2018, Does the [[microbiome]] and virome contribute to [[ME/CFS|myalgic encephalomyelitis/chronic fatigue syndrome]]?<ref name="Newberry, 2018" /> [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5843715/ (Full Text)] | *2018, Does the [[microbiome]] and virome contribute to [[ME/CFS|myalgic encephalomyelitis/chronic fatigue syndrome]]?<ref name="Newberry, 2018" /> [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5843715/ (Full Text)] | ||
*2018, Myalgic Encephalomyelitis/Chronic Fatigue Syndrome in the era of the human microbiome: persistent pathogens drive chronic symptoms by interfering with host [[metabolism]], [[gene expression]] and [[Immune system|immunity]]<ref>{{Cite journal|last=Proal|first=Amy| | *2018, Myalgic Encephalomyelitis/Chronic Fatigue Syndrome in the era of the human microbiome: persistent pathogens drive chronic symptoms by interfering with host [[metabolism]], [[gene expression]] and [[Immune system|immunity]]<ref>{{Cite journal | last = Proal | first = Amy | authorlink = Amy Proal | last2 = Marshall | first2 = Trevor | authorlink2 = Trevor Marshall | date = Nov 2018 | title = Myalgic Encephalomyelitis/Chronic Fatigue Syndrome in the era of the human microbiome: persistent pathogens drive chronic symptoms by interfering with host metabolism, gene expression and immunity|url=https://www.frontiersin.org/articles/10.3389/fped.2018.00373/full|journal=Frontiers in Pediatrics|volume=|issue=|pages=|quote=|via=|doi=10.3389/fped.2018.00373}}</ref> [https://www.frontiersin.org/articles/10.3389/fped.2018.00373/full (Abstract)] | ||
==See also== | ==See also== | ||
| Line 18: | Line 18: | ||
==References== | ==References== | ||
<references> | <references> | ||
<ref name="Navaneetharaja, 2016">{{Citation | <ref name="Navaneetharaja, 2016">{{Citation | last1 = Navaneetharaja | first1 = Navena| authorlink1 = | last2 = Griffiths | first2 = Verity| authorlink2 = | last3 = Wileman | first3 = Tom | authorlink3 = | last4 = Carding | first4 = Simon R. | authorlink4 = Simon Carding | title = A Role for the Intestinal Microbiota and Virome in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)? | journal = Journal of Clinical Medicine | volume = 5 | issue = 6 | page = 55 | date = 2016 | doi = 10.3390/jcm5060055 }}</ref> | ||
| last1 | <ref name="Newberry, 2018">{{Citation | last1 = Newberry | first1 = F. | authorlink1 = | last2 = Hsieh | first2 = S.-Y. | authorlink2 = | last3 = Wileman | first3 = T. | authorlink3 = | last4 = Carding | first4 = S.R. | authorlink4 = Simon Carding | title = Does the microbiome and virome contribute to myalgic encephalomyelitis/chronic fatigue syndrome? | journal = Clinical Science | volume = 132 | issue = 5 | page = 523–542 | date = 2018 | pmid = | doi = 10.1042/CS20171330 }}</ref> | ||
| last2 | |||
| last3 | |||
| last4 | |||
| title | |||
| journal = Journal of Clinical Medicine | |||
| date | |||
| doi | |||
}} | |||
</ref> | |||
<ref name="Newberry, 2018">{{Citation | |||
| last1 | |||
| last2 | |||
| last3 | |||
| last4 | |||
| title | |||
| journal = Clinical Science | |||
| date | |||
| pmid | |||
| doi | |||
}} | |||
</ref> | |||
</references> | </references> | ||
[[Category:Medical hypotheses]] | [[Category:Medical hypotheses]] | ||
Latest revision as of 02:10, April 2, 2023
Theory[edit | edit source]
Evidence[edit | edit source]
- 2015, Support for the Microgenderome: Associations in a Human Clinical Population (see also Sex Differences in CFS Microbiome)
- 2015, Prevotella copri and the microbial pathogenesis of rheumatoid arthritis (March)
- 2016, A Role for the Intestinal Microbiota and Virome in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)[1](Full Text)
- 2018, Does the microbiome and virome contribute to myalgic encephalomyelitis/chronic fatigue syndrome?[2] (Full Text)
- 2018, Myalgic Encephalomyelitis/Chronic Fatigue Syndrome in the era of the human microbiome: persistent pathogens drive chronic symptoms by interfering with host metabolism, gene expression and immunity[3] (Abstract)
See also[edit | edit source]
References[edit | edit source]
- ↑ Newberry, F.; Hsieh, S.-Y.; Wileman, T.; Carding, S.R. (2018), "Does the microbiome and virome contribute to myalgic encephalomyelitis/chronic fatigue syndrome?", Clinical Science, 132 (5): 523–542, doi:10.1042/CS20171330
- ↑ Proal, Amy; Marshall, Trevor (November 2018). "Myalgic Encephalomyelitis/Chronic Fatigue Syndrome in the era of the human microbiome: persistent pathogens drive chronic symptoms by interfering with host metabolism, gene expression and immunity". Frontiers in Pediatrics. doi:10.3389/fped.2018.00373.
